Roche Wins FDA Approval for Breakthrough Leukemia Drug

06.11.2013 - Swiss pharmaceutical giant Roche has received the green light from the U.S. Food and Drug Adminstration (FDA) to sell Gazyva (obinutuzumab), its new agent to treat chronic...